DE202004021633U1

DE202004021633U1 - Zusammensetzungen zur Gesamtgenom-Amplifikation und Genotypisierung

Zusammensetzungen zur Gesamtgenom-Amplifikation und Genotypisierung Download PDF

Info

Publication number: DE202004021633U1
Authority: DE; Germany
Prior art keywords: probes; array; probe; genome; fragments
Prior art date: 2003-06-20
Legal status : Expired - Lifetime

Application number

DE202004021633U

Other languages

German (de)

English (en)

Current Assignee

Illumina Inc

Original Assignee

Illumina Inc

Priority date

2003-06-20

Filing date

2004-06-17

Publication date

2009-11-26

2004-06-17 Application filed by Illumina Inc filed Critical Illumina Inc

2004-06-17 Priority claimed from PCT/US2004/019545 external-priority patent/WO2005003304A2/en

2009-11-26 Publication of DE202004021633U1 publication Critical patent/DE202004021633U1/de

2014-06-18 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

239000000203 mixture Substances 0.000 title claims abstract description 73
238000003205 genotyping method Methods 0.000 title description 51
238000013412 genome amplification Methods 0.000 title description 12
239000000523 sample Substances 0.000 claims abstract description 743
239000012634 fragment Substances 0.000 claims abstract description 492
125000003729 nucleotide group Chemical group 0.000 claims abstract description 133
108020004711 Nucleic Acid Probes Proteins 0.000 claims abstract description 53
239000002853 nucleic acid probe Substances 0.000 claims abstract description 53
102000003960 Ligases Human genes 0.000 claims abstract description 8
108090000364 Ligases Proteins 0.000 claims abstract description 8
238000000034 method Methods 0.000 claims description 402
239000002773 nucleotide Substances 0.000 claims description 116
239000000758 substrate Substances 0.000 claims description 79
238000003491 array Methods 0.000 claims description 70
241000282414 Homo sapiens Species 0.000 claims description 54
238000009739 binding Methods 0.000 claims description 50
230000027455 binding Effects 0.000 claims description 49
230000008569 process Effects 0.000 claims description 23
239000002131 composite material Substances 0.000 claims description 14
238000000206 photolithography Methods 0.000 claims description 3
150000007523 nucleic acids Chemical class 0.000 description 279
102000039446 nucleic acids Human genes 0.000 description 268
108020004707 nucleic acids Proteins 0.000 description 268
108020004414 DNA Proteins 0.000 description 245
239000013615 primer Substances 0.000 description 241
230000003321 amplification Effects 0.000 description 204
238000003199 nucleic acid amplification method Methods 0.000 description 204
238000006243 chemical reaction Methods 0.000 description 202
238000001514 detection method Methods 0.000 description 183
238000009396 hybridization Methods 0.000 description 107
238000003556 assay Methods 0.000 description 104
230000000295 complement effect Effects 0.000 description 86
210000004027 cell Anatomy 0.000 description 72
239000011324 bead Substances 0.000 description 62
230000004048 modification Effects 0.000 description 55
238000012986 modification Methods 0.000 description 55
239000002245 particle Substances 0.000 description 47
102100031780 Endonuclease Human genes 0.000 description 42
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 40
230000000694 effects Effects 0.000 description 40
239000000047 product Substances 0.000 description 40
239000003795 chemical substances by application Substances 0.000 description 38
108090000623 proteins and genes Proteins 0.000 description 34
108091034117 Oligonucleotide Proteins 0.000 description 32
238000003752 polymerase chain reaction Methods 0.000 description 32
230000015572 biosynthetic process Effects 0.000 description 31
108091032973 (ribonucleotides)n+m Proteins 0.000 description 30
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 30
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 30
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 30
230000008901 benefit Effects 0.000 description 26
229960002685 biotin Drugs 0.000 description 26
239000011616 biotin Substances 0.000 description 26
230000002829 reductive effect Effects 0.000 description 25
108700028369 Alleles Proteins 0.000 description 24
102000004190 Enzymes Human genes 0.000 description 24
108090000790 Enzymes Proteins 0.000 description 24
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
229940088598 enzyme Drugs 0.000 description 24
239000000126 substance Substances 0.000 description 24
239000000872 buffer Substances 0.000 description 23
239000000243 solution Substances 0.000 description 23
239000003153 chemical reaction reagent Substances 0.000 description 22
239000002299 complementary DNA Substances 0.000 description 22
108010014594 Heterogeneous Nuclear Ribonucleoprotein A1 Proteins 0.000 description 21
235000020958 biotin Nutrition 0.000 description 20
238000000926 separation method Methods 0.000 description 20
210000000349 chromosome Anatomy 0.000 description 19
230000014509 gene expression Effects 0.000 description 19
239000007790 solid phase Substances 0.000 description 19
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 18
230000000875 corresponding effect Effects 0.000 description 18
239000011541 reaction mixture Substances 0.000 description 18
108010042407 Endonucleases Proteins 0.000 description 17
238000004458 analytical method Methods 0.000 description 17
238000003776 cleavage reaction Methods 0.000 description 17
239000000835 fiber Substances 0.000 description 17
239000007787 solid Chemical group 0.000 description 17
240000004808 Saccharomyces cerevisiae Species 0.000 description 16
239000002253 acid Substances 0.000 description 16
239000007788 liquid Substances 0.000 description 16
-1 Cascade Blue TM Chemical compound 0.000 description 15
238000002372 labelling Methods 0.000 description 15
230000000670 limiting effect Effects 0.000 description 15
230000007017 scission Effects 0.000 description 15
238000003786 synthesis reaction Methods 0.000 description 15
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 14
230000004044 response Effects 0.000 description 14
238000007792 addition Methods 0.000 description 13
238000013459 approach Methods 0.000 description 13
201000010099 disease Diseases 0.000 description 13
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 13
238000005516 engineering process Methods 0.000 description 13
239000000463 material Substances 0.000 description 13
210000001519 tissue Anatomy 0.000 description 13
LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 12
150000007513 acids Chemical class 0.000 description 12
230000001419 dependent effect Effects 0.000 description 12
239000003550 marker Substances 0.000 description 12
230000010076 replication Effects 0.000 description 12
102000053602 DNA Human genes 0.000 description 11
238000000338 in vitro Methods 0.000 description 11
239000003112 inhibitor Substances 0.000 description 11
239000003446 ligand Substances 0.000 description 11
230000035772 mutation Effects 0.000 description 11
102000054765 polymorphisms of proteins Human genes 0.000 description 11
150000003839 salts Chemical class 0.000 description 11
108091028043 Nucleic acid sequence Proteins 0.000 description 10
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 10
230000002068 genetic effect Effects 0.000 description 10
230000003993 interaction Effects 0.000 description 10
108020004999 messenger RNA Proteins 0.000 description 10
235000018102 proteins Nutrition 0.000 description 10
102000004169 proteins and genes Human genes 0.000 description 10
230000009467 reduction Effects 0.000 description 10
230000003362 replicative effect Effects 0.000 description 10
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 9
108090001008 Avidin Proteins 0.000 description 9
241000588724 Escherichia coli Species 0.000 description 9
206010028980 Neoplasm Diseases 0.000 description 9
108010090804 Streptavidin Proteins 0.000 description 9
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical group O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 9
238000000137 annealing Methods 0.000 description 9
230000013011 mating Effects 0.000 description 9
230000037452 priming Effects 0.000 description 9
238000013518 transcription Methods 0.000 description 9
230000035897 transcription Effects 0.000 description 9
238000005406 washing Methods 0.000 description 9
108060002716 Exonuclease Proteins 0.000 description 8
108010006519 Molecular Chaperones Proteins 0.000 description 8
101710163270 Nuclease Proteins 0.000 description 8
108091081062 Repeated sequence (DNA) Proteins 0.000 description 8
241000700605 Viruses Species 0.000 description 8
108010058966 bacteriophage T7 induced DNA polymerase Proteins 0.000 description 8
239000003814 drug Substances 0.000 description 8
102000013165 exonuclease Human genes 0.000 description 8
238000013467 fragmentation Methods 0.000 description 8
238000006062 fragmentation reaction Methods 0.000 description 8
239000011521 glass Substances 0.000 description 8
230000005291 magnetic effect Effects 0.000 description 8
239000004005 microsphere Substances 0.000 description 8
230000003287 optical effect Effects 0.000 description 8
229920000642 polymer Polymers 0.000 description 8
238000011160 research Methods 0.000 description 8
241000894007 species Species 0.000 description 8
108091093037 Peptide nucleic acid Proteins 0.000 description 7
229920001213 Polysorbate 20 Polymers 0.000 description 7
101710086015 RNA ligase Proteins 0.000 description 7
208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 7
206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 7
238000004132 cross linking Methods 0.000 description 7
229940079593 drug Drugs 0.000 description 7
102000054766 genetic haplotypes Human genes 0.000 description 7
238000004519 manufacturing process Methods 0.000 description 7
230000000813 microbial effect Effects 0.000 description 7
239000004033 plastic Substances 0.000 description 7
229920003023 plastic Polymers 0.000 description 7
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 7
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 7
230000035945 sensitivity Effects 0.000 description 7
239000011780 sodium chloride Substances 0.000 description 7
108010017826 DNA Polymerase I Proteins 0.000 description 6
102000004594 DNA Polymerase I Human genes 0.000 description 6
229910019142 PO4 Inorganic materials 0.000 description 6
108010006785 Taq Polymerase Proteins 0.000 description 6
238000009826 distribution Methods 0.000 description 6
239000000975 dye Substances 0.000 description 6
230000002255 enzymatic effect Effects 0.000 description 6
238000002474 experimental method Methods 0.000 description 6
238000001506 fluorescence spectroscopy Methods 0.000 description 6
238000001943 fluorescence-activated cell sorting Methods 0.000 description 6
125000000524 functional group Chemical group 0.000 description 6
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 6
238000010348 incorporation Methods 0.000 description 6
238000011534 incubation Methods 0.000 description 6
230000002401 inhibitory effect Effects 0.000 description 6
239000005022 packaging material Substances 0.000 description 6
102000040430 polynucleotide Human genes 0.000 description 6
108091033319 polynucleotide Proteins 0.000 description 6
239000002157 polynucleotide Substances 0.000 description 6
108091008146 restriction endonucleases Proteins 0.000 description 6
ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 6
102000002260 Alkaline Phosphatase Human genes 0.000 description 5
108020004774 Alkaline Phosphatase Proteins 0.000 description 5
241000894006 Bacteria Species 0.000 description 5
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 5
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 5
102000004533 Endonucleases Human genes 0.000 description 5
108060003951 Immunoglobulin Proteins 0.000 description 5
HDRRAMINWIWTNU-NTSWFWBYSA-N [[(2s,5r)-5-(2-amino-6-oxo-3h-purin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@H]1CC[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HDRRAMINWIWTNU-NTSWFWBYSA-N 0.000 description 5
ARLKCWCREKRROD-POYBYMJQSA-N [[(2s,5r)-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)CC1 ARLKCWCREKRROD-POYBYMJQSA-N 0.000 description 5
238000001574 biopsy Methods 0.000 description 5
230000000903 blocking effect Effects 0.000 description 5
238000004422 calculation algorithm Methods 0.000 description 5
201000011510 cancer Diseases 0.000 description 5
150000001720 carbohydrates Chemical class 0.000 description 5
235000014633 carbohydrates Nutrition 0.000 description 5
229940104302 cytosine Drugs 0.000 description 5
URGJWIFLBWJRMF-JGVFFNPUSA-N ddTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)CC1 URGJWIFLBWJRMF-JGVFFNPUSA-N 0.000 description 5
238000004925 denaturation Methods 0.000 description 5
230000036425 denaturation Effects 0.000 description 5
239000000539 dimer Substances 0.000 description 5
125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
102000018358 immunoglobulin Human genes 0.000 description 5
238000011065 in-situ storage Methods 0.000 description 5
238000011901 isothermal amplification Methods 0.000 description 5
238000007834 ligase chain reaction Methods 0.000 description 5
238000011068 loading method Methods 0.000 description 5
230000011987 methylation Effects 0.000 description 5
238000007069 methylation reaction Methods 0.000 description 5
238000006011 modification reaction Methods 0.000 description 5
239000003068 molecular probe Substances 0.000 description 5
239000002777 nucleoside Substances 0.000 description 5
239000010452 phosphate Substances 0.000 description 5
238000005096 rolling process Methods 0.000 description 5
VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
210000000130 stem cell Anatomy 0.000 description 5
235000000346 sugar Nutrition 0.000 description 5
229940035893 uracil Drugs 0.000 description 5
OAKPWEUQDVLTCN-NKWVEPMBSA-N 2',3'-Dideoxyadenosine-5-triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO[P@@](O)(=O)O[P@](O)(=O)OP(O)(O)=O)O1 OAKPWEUQDVLTCN-NKWVEPMBSA-N 0.000 description 4
230000006820 DNA synthesis Effects 0.000 description 4
241000713869 Moloney murine leukemia virus Species 0.000 description 4
238000012408 PCR amplification Methods 0.000 description 4
108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 4
102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 4
101710088729 Single-stranded nucleic acid-binding protein Proteins 0.000 description 4
101710137500 T7 RNA polymerase Proteins 0.000 description 4
230000000692 anti-sense effect Effects 0.000 description 4
238000004587 chromatography analysis Methods 0.000 description 4
230000002596 correlated effect Effects 0.000 description 4
239000003431 cross linking reagent Substances 0.000 description 4
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 4
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 4
HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 4
230000006378 damage Effects 0.000 description 4
238000013461 design Methods 0.000 description 4
239000003599 detergent Substances 0.000 description 4
238000010586 diagram Methods 0.000 description 4
230000007613 environmental effect Effects 0.000 description 4
238000001914 filtration Methods 0.000 description 4
230000002209 hydrophobic effect Effects 0.000 description 4
DRAVOWXCEBXPTN-UHFFFAOYSA-N isoguanine Chemical compound NC1=NC(=O)NC2=C1NC=N2 DRAVOWXCEBXPTN-UHFFFAOYSA-N 0.000 description 4
238000002955 isolation Methods 0.000 description 4
230000001404 mediated effect Effects 0.000 description 4
238000002493 microarray Methods 0.000 description 4
125000003835 nucleoside group Chemical group 0.000 description 4
210000004940 nucleus Anatomy 0.000 description 4
239000012071 phase Substances 0.000 description 4
UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical group [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 4
230000003169 placental effect Effects 0.000 description 4
BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 4
238000012175 pyrosequencing Methods 0.000 description 4
150000003254 radicals Chemical class 0.000 description 4
239000011535 reaction buffer Substances 0.000 description 4
238000010839 reverse transcription Methods 0.000 description 4
238000012552 review Methods 0.000 description 4
238000010186 staining Methods 0.000 description 4
230000008685 targeting Effects 0.000 description 4
239000001226 triphosphate Substances 0.000 description 4
235000011178 triphosphate Nutrition 0.000 description 4
238000002604 ultrasonography Methods 0.000 description 4
229960005486 vaccine Drugs 0.000 description 4
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 3
229930024421 Adenine Natural products 0.000 description 3
238000012935 Averaging Methods 0.000 description 3
108091028732 Concatemer Proteins 0.000 description 3
108020005031 Concatenated DNA Proteins 0.000 description 3
241000252212 Danio rerio Species 0.000 description 3
108091092195 Intron Proteins 0.000 description 3
108020005187 Oligonucleotide Probes Proteins 0.000 description 3
239000004793 Polystyrene Substances 0.000 description 3
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 3
108020004682 Single-Stranded DNA Proteins 0.000 description 3
102000004357 Transferases Human genes 0.000 description 3
108090000992 Transferases Proteins 0.000 description 3
238000010521 absorption reaction Methods 0.000 description 3
229960000643 adenine Drugs 0.000 description 3
239000000853 adhesive Substances 0.000 description 3
230000001070 adhesive effect Effects 0.000 description 3
210000001789 adipocyte Anatomy 0.000 description 3
238000001042 affinity chromatography Methods 0.000 description 3
239000011543 agarose gel Substances 0.000 description 3
125000003277 amino group Chemical group 0.000 description 3
239000000427 antigen Substances 0.000 description 3
108091007433 antigens Proteins 0.000 description 3
102000036639 antigens Human genes 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
239000008280 blood Substances 0.000 description 3
230000015556 catabolic process Effects 0.000 description 3
239000013043 chemical agent Substances 0.000 description 3
230000002759 chromosomal effect Effects 0.000 description 3
230000001276 controlling effect Effects 0.000 description 3
230000001351 cycling effect Effects 0.000 description 3
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 3
NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 3
238000006731 degradation reaction Methods 0.000 description 3
238000011161 development Methods 0.000 description 3
230000029087 digestion Effects 0.000 description 3
230000009144 enzymatic modification Effects 0.000 description 3
210000003527 eukaryotic cell Anatomy 0.000 description 3
230000007717 exclusion Effects 0.000 description 3
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 3
239000004615 ingredient Substances 0.000 description 3
238000003780 insertion Methods 0.000 description 3
230000037431 insertion Effects 0.000 description 3
238000011835 investigation Methods 0.000 description 3
230000002934 lysing effect Effects 0.000 description 3
238000004949 mass spectrometry Methods 0.000 description 3
238000002844 melting Methods 0.000 description 3
230000008018 melting Effects 0.000 description 3
210000004379 membrane Anatomy 0.000 description 3
239000012528 membrane Substances 0.000 description 3
239000002105 nanoparticle Substances 0.000 description 3
210000002569 neuron Anatomy 0.000 description 3
230000007935 neutral effect Effects 0.000 description 3
230000009871 nonspecific binding Effects 0.000 description 3
239000002751 oligonucleotide probe Substances 0.000 description 3
239000013307 optical fiber Substances 0.000 description 3
239000003960 organic solvent Substances 0.000 description 3
150000004713 phosphodiesters Chemical class 0.000 description 3
238000006116 polymerization reaction Methods 0.000 description 3
229920002223 polystyrene Polymers 0.000 description 3
238000001556 precipitation Methods 0.000 description 3
239000002987 primer (paints) Substances 0.000 description 3
108090000765 processed proteins & peptides Proteins 0.000 description 3
102000004196 processed proteins & peptides Human genes 0.000 description 3
235000021251 pulses Nutrition 0.000 description 3
239000000376 reactant Substances 0.000 description 3
239000011347 resin Substances 0.000 description 3
229920005989 resin Polymers 0.000 description 3
230000002441 reversible effect Effects 0.000 description 3
238000012163 sequencing technique Methods 0.000 description 3
229910000077 silane Inorganic materials 0.000 description 3
230000005783 single-strand break Effects 0.000 description 3
238000011895 specific detection Methods 0.000 description 3
229940063673 spermidine Drugs 0.000 description 3
238000001356 surgical procedure Methods 0.000 description 3
238000012360 testing method Methods 0.000 description 3
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical group CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 3
XQCZBXHVTFVIFE-UHFFFAOYSA-N 2-amino-4-hydroxypyrimidine Chemical compound NC1=NC=CC(O)=N1 XQCZBXHVTFVIFE-UHFFFAOYSA-N 0.000 description 2
FZWGECJQACGGTI-UHFFFAOYSA-N 2-amino-7-methyl-1,7-dihydro-6H-purin-6-one Chemical class NC1=NC(O)=C2N(C)C=NC2=N1 FZWGECJQACGGTI-UHFFFAOYSA-N 0.000 description 2
GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 2
VIIIJFZJKFXOGG-UHFFFAOYSA-N 3-methylchromen-2-one Chemical compound C1=CC=C2OC(=O)C(C)=CC2=C1 VIIIJFZJKFXOGG-UHFFFAOYSA-N 0.000 description 2
OVONXEQGWXGFJD-UHFFFAOYSA-N 4-sulfanylidene-1h-pyrimidin-2-one Chemical compound SC=1C=CNC(=O)N=1 OVONXEQGWXGFJD-UHFFFAOYSA-N 0.000 description 2
RYVNIFSIEDRLSJ-UHFFFAOYSA-N 5-(hydroxymethyl)cytosine Chemical compound NC=1NC(=O)N=CC=1CO RYVNIFSIEDRLSJ-UHFFFAOYSA-N 0.000 description 2
DEQPBRIACBATHE-FXQIFTODSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-2-iminopentanoic acid Chemical compound N1C(=O)N[C@@H]2[C@H](CCCC(=N)C(=O)O)SC[C@@H]21 DEQPBRIACBATHE-FXQIFTODSA-N 0.000 description 2
LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 2
PEHVGBZKEYRQSX-UHFFFAOYSA-N 7-deaza-adenine Chemical class NC1=NC=NC2=C1C=CN2 PEHVGBZKEYRQSX-UHFFFAOYSA-N 0.000 description 2
HCGHYQLFMPXSDU-UHFFFAOYSA-N 7-methyladenine Chemical class C1=NC(N)=C2N(C)C=NC2=N1 HCGHYQLFMPXSDU-UHFFFAOYSA-N 0.000 description 2
KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
101100189379 Caenorhabditis elegans pat-9 gene Proteins 0.000 description 2
241000283707 Capra Species 0.000 description 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
241001432959 Chernes Species 0.000 description 2
108020004635 Complementary DNA Proteins 0.000 description 2
201000003883 Cystic fibrosis Diseases 0.000 description 2
HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 2
108020003215 DNA Probes Proteins 0.000 description 2
239000003298 DNA probe Substances 0.000 description 2
108010008532 Deoxyribonuclease I Proteins 0.000 description 2
102000007260 Deoxyribonuclease I Human genes 0.000 description 2
AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 2
241000255925 Diptera Species 0.000 description 2
241000196324 Embryophyta Species 0.000 description 2
241000702371 Enterobacteria phage f1 Species 0.000 description 2
229910052693 Europium Inorganic materials 0.000 description 2
108090000652 Flap endonucleases Proteins 0.000 description 2
102000004150 Flap endonucleases Human genes 0.000 description 2
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
241000233866 Fungi Species 0.000 description 2
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
108010001336 Horseradish Peroxidase Proteins 0.000 description 2
229930010555 Inosine Natural products 0.000 description 2
UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 2
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
108091092878 Microsatellite Proteins 0.000 description 2
241000699666 Mus <mouse, genus> Species 0.000 description 2
KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
239000004677 Nylon Substances 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
240000007594 Oryza sativa Species 0.000 description 2
235000007164 Oryza sativa Nutrition 0.000 description 2
241000288906 Primates Species 0.000 description 2
108010065868 RNA polymerase SP6 Proteins 0.000 description 2
241000700159 Rattus Species 0.000 description 2
108020004511 Recombinant DNA Proteins 0.000 description 2
PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 2
PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
210000001744 T-lymphocyte Anatomy 0.000 description 2
239000004809 Teflon Substances 0.000 description 2
229920006362 Teflon® Polymers 0.000 description 2
241000255588 Tephritidae Species 0.000 description 2
229910052771 Terbium Inorganic materials 0.000 description 2
241000589499 Thermus thermophilus Species 0.000 description 2
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
240000008042 Zea mays Species 0.000 description 2
NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 2
HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 2
229910052782 aluminium Inorganic materials 0.000 description 2
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical group [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
125000000539 amino acid group Chemical group 0.000 description 2
150000001413 amino acids Chemical group 0.000 description 2
239000003125 aqueous solvent Substances 0.000 description 2
238000000149 argon plasma sintering Methods 0.000 description 2
210000001130 astrocyte Anatomy 0.000 description 2
210000003719 b-lymphocyte Anatomy 0.000 description 2
108010028263 bacteriophage T3 RNA polymerase Proteins 0.000 description 2
230000004888 barrier function Effects 0.000 description 2
229960003237 betaine Drugs 0.000 description 2
230000005540 biological transmission Effects 0.000 description 2
210000001124 body fluid Anatomy 0.000 description 2
239000010839 body fluid Substances 0.000 description 2
238000010804 cDNA synthesis Methods 0.000 description 2
238000005251 capillar electrophoresis Methods 0.000 description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
239000005018 casein Substances 0.000 description 2
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
235000021240 caseins Nutrition 0.000 description 2
239000013592 cell lysate Substances 0.000 description 2
210000002421 cell wall Anatomy 0.000 description 2
239000000919 ceramic Substances 0.000 description 2
230000008859 change Effects 0.000 description 2
239000007795 chemical reaction product Substances 0.000 description 2
210000003763 chloroplast Anatomy 0.000 description 2
238000007621 cluster analysis Methods 0.000 description 2
210000001608 connective tissue cell Anatomy 0.000 description 2
239000000470 constituent Substances 0.000 description 2
238000011109 contamination Methods 0.000 description 2
230000008878 coupling Effects 0.000 description 2
238000010168 coupling process Methods 0.000 description 2
238000005859 coupling reaction Methods 0.000 description 2
230000002950 deficient Effects 0.000 description 2
230000006735 deficit Effects 0.000 description 2
238000012217 deletion Methods 0.000 description 2
230000037430 deletion Effects 0.000 description 2
230000027832 depurination Effects 0.000 description 2
230000033629 detection of yeast Effects 0.000 description 2
206010012601 diabetes mellitus Diseases 0.000 description 2
XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 2
235000011180 diphosphates Nutrition 0.000 description 2
238000010494 dissociation reaction Methods 0.000 description 2
230000005593 dissociations Effects 0.000 description 2
230000005014 ectopic expression Effects 0.000 description 2
108010093801 endodeoxyribonuclease BstNBI Proteins 0.000 description 2
YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 2
210000003743 erythrocyte Anatomy 0.000 description 2
IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 2
239000004174 erythrosine Substances 0.000 description 2
229940011411 erythrosine Drugs 0.000 description 2
235000012732 erythrosine Nutrition 0.000 description 2
OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 2
230000005284 excitation Effects 0.000 description 2
238000010195 expression analysis Methods 0.000 description 2
238000000684 flow cytometry Methods 0.000 description 2
GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 2
238000002376 fluorescence recovery after photobleaching Methods 0.000 description 2
238000001502 gel electrophoresis Methods 0.000 description 2
230000007614 genetic variation Effects 0.000 description 2
230000005484 gravity Effects 0.000 description 2
208000019622 heart disease Diseases 0.000 description 2
238000003505 heat denaturation Methods 0.000 description 2
210000003958 hematopoietic stem cell Anatomy 0.000 description 2
230000006872 improvement Effects 0.000 description 2
230000002779 inactivation Effects 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
230000000977 initiatory effect Effects 0.000 description 2
238000007641 inkjet printing Methods 0.000 description 2
229960003786 inosine Drugs 0.000 description 2
229910052747 lanthanoid Inorganic materials 0.000 description 2
150000002602 lanthanoids Chemical class 0.000 description 2
239000007791 liquid phase Substances 0.000 description 2
DLBFLQKQABVKGT-UHFFFAOYSA-L lucifer yellow dye Chemical compound [Li+].[Li+].[O-]S(=O)(=O)C1=CC(C(N(C(=O)NN)C2=O)=O)=C3C2=CC(S([O-])(=O)=O)=CC3=C1N DLBFLQKQABVKGT-UHFFFAOYSA-L 0.000 description 2
210000002540 macrophage Anatomy 0.000 description 2
FDZZZRQASAIRJF-UHFFFAOYSA-M malachite green Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](C)C)C=C1 FDZZZRQASAIRJF-UHFFFAOYSA-M 0.000 description 2
229940107698 malachite green Drugs 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
238000002483 medication Methods 0.000 description 2
229910052751 metal Inorganic materials 0.000 description 2
239000002184 metal Substances 0.000 description 2
210000003470 mitochondria Anatomy 0.000 description 2
238000002156 mixing Methods 0.000 description 2
238000010369 molecular cloning Methods 0.000 description 2
210000000440 neutrophil Anatomy 0.000 description 2
238000010606 normalization Methods 0.000 description 2
238000003499 nucleic acid array Methods 0.000 description 2
238000007826 nucleic acid assay Methods 0.000 description 2
150000003833 nucleoside derivatives Chemical class 0.000 description 2
229920001778 nylon Polymers 0.000 description 2
125000004043 oxo group Chemical group O=* 0.000 description 2
239000000123 paper Substances 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
210000002826 placenta Anatomy 0.000 description 2
229920001296 polysiloxane Polymers 0.000 description 2
239000008057 potassium phosphate buffer Substances 0.000 description 2
239000002243 precursor Substances 0.000 description 2
238000007639 printing Methods 0.000 description 2
238000012545 processing Methods 0.000 description 2
210000001236 prokaryotic cell Anatomy 0.000 description 2
239000002096 quantum dot Substances 0.000 description 2
230000005855 radiation Effects 0.000 description 2
230000001105 regulatory effect Effects 0.000 description 2
230000000717 retained effect Effects 0.000 description 2
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
229920002477 rna polymer Polymers 0.000 description 2
238000004062 sedimentation Methods 0.000 description 2
239000000377 silicon dioxide Substances 0.000 description 2
238000001542 size-exclusion chromatography Methods 0.000 description 2
239000002904 solvent Substances 0.000 description 2
238000004611 spectroscopical analysis Methods 0.000 description 2
239000003381 stabilizer Substances 0.000 description 2
PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 2
235000021286 stilbenes Nutrition 0.000 description 2
239000000725 suspension Substances 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
230000009897 systematic effect Effects 0.000 description 2
GZCRRIHWUXGPOV-UHFFFAOYSA-N terbium atom Chemical compound [Tb] GZCRRIHWUXGPOV-UHFFFAOYSA-N 0.000 description 2
WGTODYJZXSJIAG-UHFFFAOYSA-N tetramethylrhodamine chloride Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C(O)=O WGTODYJZXSJIAG-UHFFFAOYSA-N 0.000 description 2
MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 2
125000003396 thiol group Chemical group [H]S* 0.000 description 2
230000002103 transcriptional effect Effects 0.000 description 2
238000012546 transfer Methods 0.000 description 2
125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 2
UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 2
238000000108 ultra-filtration Methods 0.000 description 2
230000003612 virological effect Effects 0.000 description 2
235000012431 wafers Nutrition 0.000 description 2
BUHVIAUBTBOHAG-FOYDDCNASA-N (2r,3r,4s,5r)-2-[6-[[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]amino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound COC1=CC(OC)=CC(C(CNC=2C=3N=CN(C=3N=CN=2)[C@H]2[C@@H]([C@H](O)[C@@H](CO)O2)O)C=2C(=CC=CC=2)C)=C1 BUHVIAUBTBOHAG-FOYDDCNASA-N 0.000 description 1
UHUHBFMZVCOEOV-UHFFFAOYSA-N 1h-imidazo[4,5-c]pyridin-4-amine Chemical class NC1=NC=CC2=C1N=CN2 UHUHBFMZVCOEOV-UHFFFAOYSA-N 0.000 description 1
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
HTOVHZGIBCAAJU-UHFFFAOYSA-N 2-amino-2-propyl-1h-purin-6-one Chemical compound CCCC1(N)NC(=O)C2=NC=NC2=N1 HTOVHZGIBCAAJU-UHFFFAOYSA-N 0.000 description 1
USCCECGPGBGFOM-UHFFFAOYSA-N 2-propyl-7h-purin-6-amine Chemical compound CCCC1=NC(N)=C2NC=NC2=N1 USCCECGPGBGFOM-UHFFFAOYSA-N 0.000 description 1
LOJNBPNACKZWAI-UHFFFAOYSA-N 3-nitro-1h-pyrrole Chemical compound [O-][N+](=O)C=1C=CNC=1 LOJNBPNACKZWAI-UHFFFAOYSA-N 0.000 description 1
JLBJTVDPSNHSKJ-UHFFFAOYSA-N 4-Methylstyrene Chemical compound CC1=CC=C(C=C)C=C1 JLBJTVDPSNHSKJ-UHFFFAOYSA-N 0.000 description 1
ZLAQATDNGLKIEV-UHFFFAOYSA-N 5-methyl-2-sulfanylidene-1h-pyrimidin-4-one Chemical compound CC1=CNC(=S)NC1=O ZLAQATDNGLKIEV-UHFFFAOYSA-N 0.000 description 1
OZFPSOBLQZPIAV-UHFFFAOYSA-N 5-nitro-1h-indole Chemical compound [O-][N+](=O)C1=CC=C2NC=CC2=C1 OZFPSOBLQZPIAV-UHFFFAOYSA-N 0.000 description 1
UJBCLAXPPIDQEE-UHFFFAOYSA-N 5-prop-1-ynyl-1h-pyrimidine-2,4-dione Chemical compound CC#CC1=CNC(=O)NC1=O UJBCLAXPPIDQEE-UHFFFAOYSA-N 0.000 description 1
KXBCLNRMQPRVTP-UHFFFAOYSA-N 6-amino-1,5-dihydroimidazo[4,5-c]pyridin-4-one Chemical class O=C1NC(N)=CC2=C1N=CN2 KXBCLNRMQPRVTP-UHFFFAOYSA-N 0.000 description 1
DCPSTSVLRXOYGS-UHFFFAOYSA-N 6-amino-1h-pyrimidine-2-thione Chemical compound NC1=CC=NC(S)=N1 DCPSTSVLRXOYGS-UHFFFAOYSA-N 0.000 description 1
QNNARSZPGNJZIX-UHFFFAOYSA-N 6-amino-5-prop-1-ynyl-1h-pyrimidin-2-one Chemical compound CC#CC1=CNC(=O)N=C1N QNNARSZPGNJZIX-UHFFFAOYSA-N 0.000 description 1
CKOMXBHMKXXTNW-UHFFFAOYSA-N 6-methyladenine Chemical compound CNC1=NC=NC2=C1N=CN2 CKOMXBHMKXXTNW-UHFFFAOYSA-N 0.000 description 1
LOSIULRWFAEMFL-UHFFFAOYSA-N 7-deazaguanine Chemical class O=C1NC(N)=NC2=C1CC=N2 LOSIULRWFAEMFL-UHFFFAOYSA-N 0.000 description 1
CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
PFUVOLUPRFCPMN-UHFFFAOYSA-N 7h-purine-6,8-diamine Chemical compound C1=NC(N)=C2NC(N)=NC2=N1 PFUVOLUPRFCPMN-UHFFFAOYSA-N 0.000 description 1
HRYKDUPGBWLLHO-UHFFFAOYSA-N 8-azaadenine Chemical class NC1=NC=NC2=NNN=C12 HRYKDUPGBWLLHO-UHFFFAOYSA-N 0.000 description 1
LPXQRXLUHJKZIE-UHFFFAOYSA-N 8-azaguanine Chemical class NC1=NC(O)=C2NN=NC2=N1 LPXQRXLUHJKZIE-UHFFFAOYSA-N 0.000 description 1
229960005508 8-azaguanine Drugs 0.000 description 1
RGKBRPAAQSHTED-UHFFFAOYSA-N 8-oxoadenine Chemical compound NC1=NC=NC2=C1NC(=O)N2 RGKBRPAAQSHTED-UHFFFAOYSA-N 0.000 description 1
MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 1
102000012440 Acetylcholinesterase Human genes 0.000 description 1
108010022752 Acetylcholinesterase Proteins 0.000 description 1
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
241000251468 Actinopterygii Species 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
102100027211 Albumin Human genes 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
208000007848 Alcoholism Diseases 0.000 description 1
108091023043 Alu Element Proteins 0.000 description 1
208000024827 Alzheimer disease Diseases 0.000 description 1
DHMQDGOQFOQNFH-UHFFFAOYSA-M Aminoacetate Chemical compound NCC([O-])=O DHMQDGOQFOQNFH-UHFFFAOYSA-M 0.000 description 1
108010032595 Antibody Binding Sites Proteins 0.000 description 1
241000256844 Apis mellifera Species 0.000 description 1
241000219195 Arabidopsis thaliana Species 0.000 description 1
241000239290 Araneae Species 0.000 description 1
235000007319 Avena orientalis Nutrition 0.000 description 1
244000075850 Avena orientalis Species 0.000 description 1
241000322342 Bacillus phage M2 Species 0.000 description 1
241000701844 Bacillus virus phi29 Species 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
240000002791 Brassica napus Species 0.000 description 1
235000004977 Brassica sinapistrum Nutrition 0.000 description 1
241000244203 Caenorhabditis elegans Species 0.000 description 1
241000701459 Caulimovirus Species 0.000 description 1
241000700199 Cavia porcellus Species 0.000 description 1
241000195597 Chlamydomonas reinhardtii Species 0.000 description 1
108010077544 Chromatin Proteins 0.000 description 1
108020004638 Circular DNA Proteins 0.000 description 1
108020001738 DNA Glycosylase Proteins 0.000 description 1
102000012410 DNA Ligases Human genes 0.000 description 1
108010061982 DNA Ligases Proteins 0.000 description 1
108020001019 DNA Primers Proteins 0.000 description 1
238000007400 DNA extraction Methods 0.000 description 1
102000028381 DNA glycosylase Human genes 0.000 description 1
239000003155 DNA primer Substances 0.000 description 1
241000450599 DNA viruses Species 0.000 description 1
102000010719 DNA-(Apurinic or Apyrimidinic Site) Lyase Human genes 0.000 description 1
108010063362 DNA-(Apurinic or Apyrimidinic Site) Lyase Proteins 0.000 description 1
108010092160 Dactinomycin Proteins 0.000 description 1
XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
241000168726 Dictyostelium discoideum Species 0.000 description 1
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
241000255601 Drosophila melanogaster Species 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
101800001466 Envelope glycoprotein E1 Proteins 0.000 description 1
241000283073 Equus caballus Species 0.000 description 1
108010007577 Exodeoxyribonuclease I Proteins 0.000 description 1
108700024394 Exon Proteins 0.000 description 1
102100029075 Exonuclease 1 Human genes 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
239000004606 Fillers/Extenders Substances 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
108700039691 Genetic Promoter Regions Proteins 0.000 description 1
241000193385 Geobacillus stearothermophilus Species 0.000 description 1
102100036263 Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial Human genes 0.000 description 1
244000068988 Glycine max Species 0.000 description 1
235000010469 Glycine max Nutrition 0.000 description 1
108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
239000007995 HEPES buffer Substances 0.000 description 1
241000711549 Hepacivirus C Species 0.000 description 1
241000700721 Hepatitis B virus Species 0.000 description 1
241000238631 Hexapoda Species 0.000 description 1
101001001786 Homo sapiens Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial Proteins 0.000 description 1
241000725303 Human immunodeficiency virus Species 0.000 description 1
241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
108090001090 Lectins Proteins 0.000 description 1
102000004856 Lectins Human genes 0.000 description 1
241000270322 Lepidosauria Species 0.000 description 1
241000721701 Lynx Species 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
108060004795 Methyltransferase Proteins 0.000 description 1
108010059724 Micrococcal Nuclease Proteins 0.000 description 1
108020005196 Mitochondrial DNA Proteins 0.000 description 1
101100172630 Mus musculus Eri1 gene Proteins 0.000 description 1
101001024425 Mus musculus Ig gamma-2A chain C region secreted form Proteins 0.000 description 1
241000204031 Mycoplasma Species 0.000 description 1
241000863422 Myxococcus xanthus Species 0.000 description 1
241000244206 Nematoda Species 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
229910004679 ONO2 Inorganic materials 0.000 description 1
101150054516 PRD1 gene Proteins 0.000 description 1
108091081548 Palindromic sequence Proteins 0.000 description 1
241000238124 Paralithodes camtschaticus Species 0.000 description 1
208000018737 Parkinson disease Diseases 0.000 description 1
241001494479 Pecora Species 0.000 description 1
241000009328 Perro Species 0.000 description 1
108010004729 Phycoerythrin Proteins 0.000 description 1
241000223960 Plasmodium falciparum Species 0.000 description 1
241000233872 Pneumocystis carinii Species 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
108010066717 Q beta Replicase Proteins 0.000 description 1
239000013614 RNA sample Substances 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
101100459905 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) NCP1 gene Proteins 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
229920002684 Sepharose Polymers 0.000 description 1
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
244000062793 Sorghum vulgare Species 0.000 description 1
241000295644 Staphylococcaceae Species 0.000 description 1
101100054666 Streptomyces halstedii sch3 gene Proteins 0.000 description 1
208000006011 Stroke Diseases 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
241000282898 Sus scrofa Species 0.000 description 1
101150104425 T4 gene Proteins 0.000 description 1
241001441723 Takifugu Species 0.000 description 1
241001441722 Takifugu rubripes Species 0.000 description 1
241000589596 Thermus Species 0.000 description 1
101800001690 Transmembrane protein gp41 Proteins 0.000 description 1
235000021307 Triticum Nutrition 0.000 description 1
244000098338 Triticum aestivum Species 0.000 description 1
240000004922 Vigna radiata Species 0.000 description 1
235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
241000726445 Viroids Species 0.000 description 1
241000269368 Xenopus laevis Species 0.000 description 1
235000007244 Zea mays Nutrition 0.000 description 1
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
235000002017 Zea mays subsp mays Nutrition 0.000 description 1
OTXOHOIOFJSIFX-POYBYMJQSA-N [[(2s,5r)-5-(2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(=O)O)CC[C@@H]1N1C(=O)NC(=O)C=C1 OTXOHOIOFJSIFX-POYBYMJQSA-N 0.000 description 1
238000004847 absorption spectroscopy Methods 0.000 description 1
210000003892 absorptive cell Anatomy 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
229940022698 acetylcholinesterase Drugs 0.000 description 1
RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 1
230000009471 action Effects 0.000 description 1
230000004913 activation Effects 0.000 description 1
210000004504 adult stem cell Anatomy 0.000 description 1
201000007930 alcohol dependence Diseases 0.000 description 1
150000001299 aldehydes Chemical group 0.000 description 1
125000001931 aliphatic group Chemical group 0.000 description 1
125000000217 alkyl group Chemical group 0.000 description 1
230000004075 alteration Effects 0.000 description 1
150000001408 amides Chemical group 0.000 description 1
150000001412 amines Chemical group 0.000 description 1
125000005122 aminoalkylamino group Chemical group 0.000 description 1
210000004381 amniotic fluid Anatomy 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
150000004982 aromatic amines Chemical group 0.000 description 1
206010003246 arthritis Diseases 0.000 description 1
125000003710 aryl alkyl group Chemical group 0.000 description 1
208000006673 asthma Diseases 0.000 description 1
150000007514 bases Chemical class 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
102000005936 beta-Galactosidase Human genes 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
239000012620 biological material Substances 0.000 description 1
238000004061 bleaching Methods 0.000 description 1
210000000601 blood cell Anatomy 0.000 description 1
210000001772 blood platelet Anatomy 0.000 description 1
238000010504 bond cleavage reaction Methods 0.000 description 1
210000002449 bone cell Anatomy 0.000 description 1
210000004271 bone marrow stromal cell Anatomy 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
229910052794 bromium Inorganic materials 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
238000007707 calorimetry Methods 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
150000001735 carboxylic acids Chemical group 0.000 description 1
210000004413 cardiac myocyte Anatomy 0.000 description 1
239000000969 carrier Substances 0.000 description 1
210000003321 cartilage cell Anatomy 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
210000002230 centromere Anatomy 0.000 description 1
210000001175 cerebrospinal fluid Anatomy 0.000 description 1
230000003196 chaotropic effect Effects 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
238000010382 chemical cross-linking Methods 0.000 description 1
238000007385 chemical modification Methods 0.000 description 1
229910052801 chlorine Inorganic materials 0.000 description 1
125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
210000001612 chondrocyte Anatomy 0.000 description 1
210000003483 chromatin Anatomy 0.000 description 1
239000013611 chromosomal DNA Substances 0.000 description 1
238000004891 communication Methods 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
230000001010 compromised effect Effects 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
239000005289 controlled pore glass Substances 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
235000005822 corn Nutrition 0.000 description 1
DMSZORWOGDLWGN-UHFFFAOYSA-N ctk1a3526 Chemical compound NP(N)(N)=O DMSZORWOGDLWGN-UHFFFAOYSA-N 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
229960000640 dactinomycin Drugs 0.000 description 1
230000034994 death Effects 0.000 description 1
239000003398 denaturant Substances 0.000 description 1
239000000412 dendrimer Substances 0.000 description 1
229920000736 dendritic polymer Polymers 0.000 description 1
238000000432 density-gradient centrifugation Methods 0.000 description 1
239000005547 deoxyribonucleotide Substances 0.000 description 1
125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
238000000151 deposition Methods 0.000 description 1
230000008021 deposition Effects 0.000 description 1
238000010511 deprotection reaction Methods 0.000 description 1
230000001066 destructive effect Effects 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
238000002405 diagnostic procedure Methods 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
NAGJZTKCGNOGPW-UHFFFAOYSA-K dioxido-sulfanylidene-sulfido-$l^{5}-phosphane Chemical compound [O-]P([O-])([S-])=S NAGJZTKCGNOGPW-UHFFFAOYSA-K 0.000 description 1
229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
230000005782 double-strand break Effects 0.000 description 1
238000009510 drug design Methods 0.000 description 1
230000036267 drug metabolism Effects 0.000 description 1
238000012943 effectiveness check Methods 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
238000010828 elution Methods 0.000 description 1
210000001671 embryonic stem cell Anatomy 0.000 description 1
108010064144 endodeoxyribonuclease VII Proteins 0.000 description 1
210000003158 enteroendocrine cell Anatomy 0.000 description 1
230000002327 eosinophilic effect Effects 0.000 description 1
210000002919 epithelial cell Anatomy 0.000 description 1
238000005530 etching Methods 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
238000000605 extraction Methods 0.000 description 1
210000003608 fece Anatomy 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
230000004992 fission Effects 0.000 description 1
239000012530 fluid Substances 0.000 description 1
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
238000002866 fluorescence resonance energy transfer Methods 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
239000011888 foil Substances 0.000 description 1
230000003325 follicular Effects 0.000 description 1
239000000499 gel Substances 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
239000010437 gem Substances 0.000 description 1
108091008053 gene clusters Proteins 0.000 description 1
238000011331 genomic analysis Methods 0.000 description 1
210000004602 germ cell Anatomy 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
235000011187 glycerol Nutrition 0.000 description 1
210000002175 goblet cell Anatomy 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
239000010931 gold Substances 0.000 description 1
239000010439 graphite Substances 0.000 description 1
229910002804 graphite Inorganic materials 0.000 description 1
239000005090 green fluorescent protein Substances 0.000 description 1
230000012010 growth Effects 0.000 description 1
230000003760 hair shine Effects 0.000 description 1
229910052736 halogen Inorganic materials 0.000 description 1
125000001475 halogen functional group Chemical group 0.000 description 1
150000002367 halogens Chemical class 0.000 description 1
125000000592 heterocycloalkyl group Chemical group 0.000 description 1
238000000265 homogenisation Methods 0.000 description 1
229940042795 hydrazides for tuberculosis treatment Drugs 0.000 description 1
229920001477 hydrophilic polymer Polymers 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
229910052740 iodine Inorganic materials 0.000 description 1
230000001678 irradiating effect Effects 0.000 description 1
230000001788 irregular Effects 0.000 description 1
230000000155 isotopic effect Effects 0.000 description 1
238000005304 joining Methods 0.000 description 1
210000002510 keratinocyte Anatomy 0.000 description 1
239000004816 latex Substances 0.000 description 1
229920000126 latex Polymers 0.000 description 1
239000002523 lectin Substances 0.000 description 1
210000000265 leukocyte Anatomy 0.000 description 1
238000001459 lithography Methods 0.000 description 1
210000005229 liver cell Anatomy 0.000 description 1
230000033001 locomotion Effects 0.000 description 1
HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
210000002751 lymph Anatomy 0.000 description 1
230000002101 lytic effect Effects 0.000 description 1
UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
229910001629 magnesium chloride Inorganic materials 0.000 description 1
239000006249 magnetic particle Substances 0.000 description 1
125000005439 maleimidyl group Chemical group C1(C=CC(N1*)=O)=O 0.000 description 1
210000002901 mesenchymal stem cell Anatomy 0.000 description 1
239000000693 micelle Substances 0.000 description 1
239000011325 microbead Substances 0.000 description 1
235000019713 millet Nutrition 0.000 description 1
230000003278 mimic effect Effects 0.000 description 1
238000005065 mining Methods 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
210000001616 monocyte Anatomy 0.000 description 1
238000000465 moulding Methods 0.000 description 1
210000000663 muscle cell Anatomy 0.000 description 1
LCNBIHVSOPXFMR-UHFFFAOYSA-N n'-(3-aminopropyl)butane-1,4-diamine;hydron;trichloride Chemical compound Cl.Cl.Cl.NCCCCNCCCN LCNBIHVSOPXFMR-UHFFFAOYSA-N 0.000 description 1
ZTLGJPIZUOVDMT-UHFFFAOYSA-N n,n-dichlorotriazin-4-amine Chemical compound ClN(Cl)C1=CC=NN=N1 ZTLGJPIZUOVDMT-UHFFFAOYSA-N 0.000 description 1
210000000822 natural killer cell Anatomy 0.000 description 1
230000001338 necrotic effect Effects 0.000 description 1
210000005170 neoplastic cell Anatomy 0.000 description 1
210000001178 neural stem cell Anatomy 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
125000001893 nitrooxy group Chemical group [O-][N+](=O)O* 0.000 description 1
238000002414 normal-phase solid-phase extraction Methods 0.000 description 1
210000004248 oligodendroglia Anatomy 0.000 description 1
238000005457 optimization Methods 0.000 description 1
210000003463 organelle Anatomy 0.000 description 1
125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 1
230000008723 osmotic stress Effects 0.000 description 1
210000000963 osteoblast Anatomy 0.000 description 1
210000004409 osteocyte Anatomy 0.000 description 1
239000006174 pH buffer Substances 0.000 description 1
238000012856 packing Methods 0.000 description 1
210000003134 paneth cell Anatomy 0.000 description 1
230000005298 paramagnetic effect Effects 0.000 description 1
239000002907 paramagnetic material Substances 0.000 description 1
244000045947 parasite Species 0.000 description 1
244000052769 pathogen Species 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
230000035515 penetration Effects 0.000 description 1
239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
210000001778 pluripotent stem cell Anatomy 0.000 description 1
229920000058 polyacrylate Polymers 0.000 description 1
229920001748 polybutylene Polymers 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
229920000136 polysorbate Polymers 0.000 description 1
229920002635 polyurethane Polymers 0.000 description 1
239000004814 polyurethane Substances 0.000 description 1
239000011148 porous material Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
230000003449 preventive effect Effects 0.000 description 1
125000006239 protecting group Chemical group 0.000 description 1
208000020016 psychiatric disease Diseases 0.000 description 1
238000000746 purification Methods 0.000 description 1
239000002213 purine nucleotide Substances 0.000 description 1
150000003212 purines Chemical class 0.000 description 1
239000002719 pyrimidine nucleotide Substances 0.000 description 1
150000003230 pyrimidines Chemical class 0.000 description 1
238000003908 quality control method Methods 0.000 description 1
239000010453 quartz Substances 0.000 description 1
238000010791 quenching Methods 0.000 description 1
230000000171 quenching effect Effects 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
239000012857 radioactive material Substances 0.000 description 1
230000035484 reaction time Effects 0.000 description 1
238000007634 remodeling Methods 0.000 description 1
230000003252 repetitive effect Effects 0.000 description 1
239000003161 ribonuclease inhibitor Substances 0.000 description 1
150000003290 ribose derivatives Chemical group 0.000 description 1
235000009566 rice Nutrition 0.000 description 1
238000007363 ring formation reaction Methods 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
238000005464 sample preparation method Methods 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
238000010008 shearing Methods 0.000 description 1
208000007056 sickle cell anemia Diseases 0.000 description 1
238000007086 side reaction Methods 0.000 description 1
230000011664 signaling Effects 0.000 description 1
229910052709 silver Inorganic materials 0.000 description 1
239000004332 silver Substances 0.000 description 1
210000003491 skin Anatomy 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
210000000329 smooth muscle myocyte Anatomy 0.000 description 1
229910001415 sodium ion Inorganic materials 0.000 description 1
239000002689 soil Substances 0.000 description 1
239000008279 sol Substances 0.000 description 1
238000010532 solid phase synthesis reaction Methods 0.000 description 1
238000010530 solution phase reaction Methods 0.000 description 1
230000006641 stabilisation Effects 0.000 description 1
238000011105 stabilization Methods 0.000 description 1
229910001220 stainless steel Inorganic materials 0.000 description 1
239000010935 stainless steel Substances 0.000 description 1
230000003068 static effect Effects 0.000 description 1
238000007619 statistical method Methods 0.000 description 1
238000003860 storage Methods 0.000 description 1
125000000547 substituted alkyl group Chemical group 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
150000003871 sulfonates Chemical group 0.000 description 1
150000003467 sulfuric acid derivatives Chemical group 0.000 description 1
238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
210000004243 sweat Anatomy 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
238000010189 synthetic method Methods 0.000 description 1
210000001138 tear Anatomy 0.000 description 1
108091035539 telomere Proteins 0.000 description 1
102000055501 telomere Human genes 0.000 description 1
210000003411 telomere Anatomy 0.000 description 1
210000002435 tendon Anatomy 0.000 description 1
238000005382 thermal cycling Methods 0.000 description 1
RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
ZCUFMDLYAMJYST-UHFFFAOYSA-N thorium dioxide Chemical compound O=[Th]=O ZCUFMDLYAMJYST-UHFFFAOYSA-N 0.000 description 1
229940113082 thymine Drugs 0.000 description 1
239000004408 titanium dioxide Substances 0.000 description 1
238000000954 titration curve Methods 0.000 description 1
238000012549 training Methods 0.000 description 1
125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 1
PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 1
ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
238000012795 verification Methods 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1